SUBSCRIBE
SUBSCRIBE
Gail Dutton

Gail Dutton

Freelance writer

Gail Dutton is a veteran biopharmaceutical reporter, covering the industry from Washington state. You can contact her at gaildutton@gmail.com and see more of her work on Muckrack.

Biotech Beach
Study Illuminates Possible Link Between COVID-19 and Parkinson’s Disease
The findings may have far-reaching consequences for any COVID-19 vaccines in development that are based upon targeting the well-conserved SARS-CoV-2 nucleocapsid (N-) protein.
December 19, 2021
 · 
4 min read
 · 
Gail Dutton
Biotech Beach
How Pharma and Academia are Tackling the Opioid Epidemic
Deaths from drug overdoses have been on an upward trajectory for years, but have experienced a notable increase since the early days of the COVID-19 pandemic.
December 16, 2021
 · 
5 min read
 · 
Gail Dutton
Mike Kemp/In PIctures via Getty Images
Biotech Bay
J.P. Morgan Goes Virtual as Key Companies Back Out
Many big companies, including Amgen, Moderna, Roche and Novartis, had already decided not to attend in-person and the sentiment was leaning that way.
December 15, 2021
 · 
5 min read
 · 
Gail Dutton
Genetown
Set Your Data Management Strategy Early for Long-term Biotech Success
Good data management means developing a systematic way to integrate and update data enterprise-wide and to share it with team members or partners as needed.
December 14, 2021
 · 
4 min read
 · 
Gail Dutton
Marc Voigt_courtesy of Immutep S.A./Dr. Omid Hamid
Drug Development
Targeted Therapies Plus Radiation on Cusp of Making an Impact for Patients
Now, researchers are on the threshold of great changes that have the potential to transform non-curable diseases into those that can be cured.
December 12, 2021
 · 
5 min read
 · 
Gail Dutton
Drug Development
Engrafting Bacteria for Therapeutic Advantage in Kidney-Related Diseases
Proof of concept for the Genetically Engineered Microbial Medicines (GEMM) platform came in a recent first-in-human, Phase I trial.
December 6, 2021
 · 
4 min read
 · 
Gail Dutton
Business
Mix-and-Match Vaccine Platform May Boost Immune Response & Duration
IDRI is working with a newly-formed consortium to develop a next-gen COVID-19 vaccine that will be stable at routine temperatures and that may be able to confer immunity for a longer duration.
December 2, 2021
 · 
4 min read
 · 
Gail Dutton
Genetown
Human Skin Replaces Some Animal Testing, Expedites Drug Development
Genoskin’s solution is to develop the technologies to replace animals and humans in clinical studies with virtual models, steadily pushing living creatures further and further from testing.
November 30, 2021
 · 
4 min read
 · 
Gail Dutton
Drug Development
Terns is Flirting with Milestones in Challenging NASH Space
Treatment for non-alcoholic steatohepatitis (NASH), a severe form of fatty liver disease, consists mainly of lifestyle modification – specifically dieting and weight loss.
November 27, 2021
 · 
4 min read
 · 
Gail Dutton
Policy
USDA Cautiously Optimistic About SARS-CoV-2 Spread in Wildlife Populations
A preprint in bioRxiv from Penn State showed SARS-CoV-2 was detected in 33% (94) of the 283 white-tailed deer tested in Iowa between November 23, 2020 and January 10, 2021.
November 23, 2021
 · 
4 min read
 · 
Gail Dutton
Genetown
Glympse Reports Near-Perfect Accuracy with Liquid Biopsy to Predict NASH
This liquid biopsy uses a panel of peptide biosensors to analyze protein activity from a blood sample and provide actionable readouts of the disease state.
November 22, 2021
 · 
4 min read
 · 
Gail Dutton
Business
Investment Banking Prowess Paved Jennifer Jarrett’s Path to Arcus Biosciences
“I hope to thread the needle between pricing responsibly and achieving profitability,” Jarrett said.
November 21, 2021
 · 
4 min read
 · 
Gail Dutton
Genetown
Avrobio’s Small Trials Hint at Cure for 3 Big Lysosomal Diseases
Avrobio’s ex vivo lentiviral gene therapy platform led to durable responses measured in years, and significant reductions in disease-related biomarkers that far exceed today’s standard of care.
November 18, 2021
 · 
4 min read
 · 
Gail Dutton
Business
Science is an Art for Urovant CMO Cornelia Haag-Molkenteller
Her career as a physician and scientist is guided by a combination of logic and creativity.
November 17, 2021
 · 
5 min read
 · 
Gail Dutton
Drug Development
AAV Pioneer Guangping Gao Created Hope for Canavan Disease Cure
After 32 years, gene therapy pioneer Guangping Gao, Ph.D., is finally seeing the fruits of the doctoral thesis research he started in 1989.
November 16, 2021
 · 
5 min read
 · 
Gail Dutton
Load More